$WX News
Last published 9y ago
- 9y agoWXPACTMOMOATHMWhen Exile Beats China's BackdoorBloombergU.S. valuations have climbed while some firms that went private have ended up in limbo.
- 12y agoFMIWXFoundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in ChinaBusiness WireCAMBRIDGE, Mass. & SHANGHAI--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX) today announced a collaboration to offer Foundation Medicine’s comprehensive genomic profiling to biopharmaceutical companies conducting clinical trials in China.
- 12y agoILMNWXWuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing SystemBusiness WireSAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, today announced that the WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
- 13y agoSTPFQFENGWXWuXi Tops First Jump in Month on Profits: China OvernightBloombergChinese equities rose in New York, headed for their first weekly advance in more than a month, as signs of a recovery in the world’s second-biggest economy bolstered earnings.
- 15y agoBMYWXBristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing FacilityBusiness WireNEW YORK & SHANGHAI--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and WuXi PharmaTech (NYSE: WX) today announced that they have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications.